2022年T1International横断面网络调查:胰岛素和糖尿病用品的自付费用与配给(数据表1)
2022年T1International网络横断面调查数据表,记录1型糖尿病患者的胰岛素及糖尿病用品自付费用、配给情况与COVID-19影响。

基本信息
资源简介
2022年T1International横断面网络调查:胰岛素和糖尿病用品的自付费用与配给(数据表1)
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 75.92 KB,主题涵盖 type 1 diabetes、T1D、insulin、rationing、out-of-pocket expenses,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey.pdf》。配套论文《Costs and underuse of insulin and diabetes supplies: Findings from the 2020 T1International cross-sectional web-based survey》发表于 Diabetes Research and Clinical Practice(2021),DOI:10.1016/j.diabres.2021.108996。源站首次发布:2024-04-22。
【数据内容】
源站原始描述:IntroductionContinue investigating Out-of-Pocket Expenses (OoPEs) and rationing of insulin and diabetes supplies, including impacts of the COVID-19 pandemic, for people with type 1 diabetes (T1D). MethodsA cross-sectional web-based survey was conducted in English and advertised by T1International’s global network of patient advocates from May through September 2022. Participants provided monthly OoPEs and rationing frequency for insulin and supplies, impacts of the COVID-19 pandemic, and open-en…
中文译文(机器翻译,仅供快速理解,请以原文为准):引言继续调查1型糖尿病(T1D)患者的自付费用(OoPEs)以及胰岛素和糖尿病用品的配给情况,包括COVID-19疫情的影响。 方法于2022年5月至9月,通过T1International全球患者倡导者网络以英语开展了一项横断面网络调查。参与者提供了每月自付费用和胰岛素及用品的配给频率、COVID-19疫情的影响以及开放式评论。 结果在最具代表性的七个国家中,平均每月自付费用以美国最高,其次是巴拿马、加拿大和印度,而在英国、德国和瑞典则低得多。自付费用在部分医疗覆盖的参与者中最高,其次是无医疗覆盖的参与者。COVID-19疫情对超过一半参与者的胰岛素和/或用品的可及性和/或可负担性产生了负面影响。在全球范围内,19.5%报告了胰岛素配给,36.6%报告了血糖检测用品配给。对开放式回答的定性分析确定了诸如“心理健康影响”和“生活选择受限”等主题。 讨论高自付费用导致全球许多T1D患者对胰岛素和用品进行配给。需要改善医疗系统并降低胰岛素和用品价格,以确保所有人获得充足、公平的可及性。
【数据结构与技术规格】
文件数 1 个,合计 75.92 KB。Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based s.pdf:application/pdf,75.92 KB。数据集 DOI:10.3389/fcdhc.2024.1293882.s001。
【主题与分类】
源站学科分类:Metabolic Medicine。主题标签:type 1 diabetes、T1D、insulin、rationing、out-of-pocket expenses、COVID-19、health policy、health equity。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Out-of-pocket_expenses_and_rationing_of_insulin_and_diabetes_supplies_findings_from_the_2022_T1International_cross-sectional_web-based_survey_pdf/25662378
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Souris, Katherine Janine; Pfiester, Elizabeth; Thieffry, Axel; Chen, Yanbing; Braune, Katarina; Bhargava, Mridula Kapil; et al. (2024). Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey.pdf. Fro…
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based survey.pdf
- DOI:10.3389/fcdhc.2024.1293882.s001
- 发布日期:2024-04-22
- 文件数:1 个
- 文件总体积:75.92 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Out-of-pocket_expenses_and_rationing_of_insulin_and_diabetes_supplies_findings_from_the_2022_T1International_cross-sectional_web-based_survey_pdf/25662378
命令行下载
curl -L -o "Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based s.pdf" "https://ndownloader.figshare.com/files/45777780"
文件清单
Data Sheet 1_Out-of-pocket expenses and rationing of insulin and diabetes supplies: findings from the 2022 T1International cross-sectional web-based s.pdf(75.92 KB)
文件总体积 75.92 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
IntroductionContinue investigating Out-of-Pocket Expenses (OoPEs) and rationing of insulin and diabetes supplies, including impacts of the COVID-19 pandemic, for people with type 1 diabetes (T1D).
MethodsA cross-sectional web-based survey was conducted in English and advertised by T1International’s global network of patient advocates from May through September 2022. Participants provided monthly OoPEs and rationing frequency for insulin and supplies, impacts of the COVID-19 pandemic, and open-ended comments.
ResultsIn the seven most represented countries, mean monthly OoPEs were highest in the United States, followed by Panama, Canada, and India, and were much lower in the United Kingdom, Germany, and Sweden. OoPEs were highest for participants with partial healthcare coverage, followed by those with no healthcare coverage. The COVID-19 pandemic negatively impacted access and/or affordability of insulin and/or supplies for over half of participants. Globally, 19.5% reported insulin rationing and 36.6% reported rationing glucose testing supplies. Qualitative analysis of open-ended responses identified themes such as ‘mental health impacts’ and ‘limits to life choices.’
DiscussionHigh OoPEs lead to rationing of insulin and supplies for many people with T1D globally. Healthcare systems improvements and price reductions of insulin and supplies are needed to ensure adequate, equitable access for all.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fcdhc.2024.1293882.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Out-of-pocket_expenses_and_rationing_of_insulin_and_diabetes_supplies_findings_from_the_2022_T1International_cross-sectional_web-based_survey_pdf/25662378)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




